Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q16539
UPID:
MK14_HUMAN
Alternative names:
Cytokine suppressive anti-inflammatory drug-binding protein; MAP kinase MXI2; MAX-interacting protein 2; Mitogen-activated protein kinase p38 alpha; Stress-activated protein kinase 2a
Alternative UPACC:
Q16539; A6ZJ92; A8K6P4; B0LPH0; B5TY32; O60776; Q13083; Q14084; Q8TDX0
Background:
Mitogen-activated protein kinase 14 (MAPK14), also known as p38 alpha, plays a pivotal role in the MAP kinase signal transduction pathway. It is activated by various extracellular stimuli, leading to the phosphorylation of numerous substrates involved in inflammatory responses, stress, and mitogenic stimuli. MAPK14's interaction with kinases and transcription factors facilitates immediate-early gene induction, protein synthesis regulation, and apoptosis inhibition.
Therapeutic significance:
Understanding the role of Mitogen-activated protein kinase 14 could open doors to potential therapeutic strategies. Its involvement in key cellular processes such as inflammation, stress response, and cell proliferation makes it a promising target for drug discovery efforts aimed at treating related diseases.